These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14872431)

  • 1. Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities.
    Rodriguez-Merchan EC; Wiedel Jd Jd; Wallny T; Caviglia H; Hvid I; Berntorp E; Rivard GE; Goddard Nj Nj; Querol F
    Semin Hematol; 2004 Jan; 41(1 Suppl 1):109-16. PubMed ID: 14872431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elective orthopaedic surgery for inhibitor patients.
    Rodriguez-Merchan EC; Wiedel JD; Wallny T; Hvid I; Berntorp E; Rivard GE; Goddard NJ; Querol F; Caviglia H
    Haemophilia; 2003 Sep; 9(5):625-31. PubMed ID: 14511305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
    Caviglia H; Candela M; Galatro G; Neme D; Moretti N; Bianco RP
    Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying and managing inhibitor patients requiring orthopaedic surgery - the multidisciplinary team approach.
    Ludlam C
    Haemophilia; 2005 Nov; 11 Suppl 1():7-10. PubMed ID: 16219043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
    Ballal RD; Botteman MF; Foley I; Stephens JM; Wilke CT; Joshi AV
    Curr Med Res Opin; 2008 Mar; 24(3):753-68. PubMed ID: 18234151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
    Scharrer I
    Haemophilia; 1999 Jul; 5(4):253-9. PubMed ID: 10469179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of haemophilic patients with inhibitors in major orthopaedic surgery by immunadsorption, substitution of factor VIII and recombinant factor VIIa (NovoSeven): a single centre experience.
    Habermann B; Hochmuth K; Hovy L; Scharrer I; Kurth AH
    Haemophilia; 2004 Nov; 10(6):705-12. PubMed ID: 15569165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.
    Ingerslev J
    Semin Thromb Hemost; 2000; 26(4):425-32. PubMed ID: 11092219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthopedic surgery is possible in hemophilic patients with inhibitors.
    Rodríguez-Merchán EC
    Am J Orthop (Belle Mead NJ); 2012 Dec; 41(12):570-4. PubMed ID: 23431528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience.
    Rodriguez-Merchan EC; Jimenez-Yuste V; Gomez-Cardero P; Alvarez-Roman M; Martin-Salces M; Rodriguez de la Rua A
    Haemophilia; 2010 May; 16(102):84-8. PubMed ID: 20536990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
    Hvid I; Rodriguez-Merchan EC
    Haemophilia; 2002 May; 8(3):288-91. PubMed ID: 12010425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
    Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
    Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor VIIa (Novoseven) and the safety of treatment.
    Roberts HR
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):48-50. PubMed ID: 11735111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
    Valentino LA; Cooper DL; Goldstein B
    Haemophilia; 2011 Jul; 17(4):579-89. PubMed ID: 21294815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive pseudotumour resection with recombinant factor VIIa (NovoSeven) cover.
    O'Connell N; Chen J; Byrne M; O'Shea E; Smyth H; Smith OP
    Br J Haematol; 2002 Mar; 116(3):645-8. PubMed ID: 11849225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.
    Takedani H; Kawahara H; Kajiwara M
    Haemophilia; 2010 Mar; 16(2):290-5. PubMed ID: 19925628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies and challenges in elective orthopedic surgery in patients with hemophilia and inhibitors.
    Jiménez-Yuste V; Rodriguez-Merchan EC; Alvarez MT; Quintana M; Fernandez I; Hernandez-Navarro F
    Semin Hematol; 2008 Apr; 45(2 Suppl 1):S64-7. PubMed ID: 18544428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.
    Kraut EH; Aledort LM; Arkin S; Stine KC; Wong WY
    Haemophilia; 2007 Sep; 13(5):508-17. PubMed ID: 17880437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.
    Stephens JM; Joshi AV; Sumner M; Botteman MF
    Expert Opin Pharmacother; 2007 Jun; 8(8):1127-36. PubMed ID: 17516876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
    Obergfell A; Auvinen MK; Mathew P
    Haemophilia; 2008 Mar; 14(2):233-41. PubMed ID: 18081827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.